BB Biotech AG (XSWX:BION) Receivables Turnover: (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:BION BB Biotech AG XSWX:BION
34 GF Score
Price CHF50.60
! 4 Warning Signs
View Full Analysis

What is BB Biotech AG Receivables Turnover?

Receivables Turnover does not apply to banks and insurance companies.

XSWX:BION
34GF Score
BB Biotech AG XSWX:BION
Receivables Turnover is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BB Biotech AG Business Description

Address Schwertstrasse 6, Schaffhausen, CHE, CH-8200
BB Biotech AG is a part of the healthcare sector in Switzerland. Its primary activity includes making investments, especially in the biotechnology market, and is one of the investors in the field of biotechnology. The focus of the investments is on those listed companies that focus on the development and marketing of novel drugs with a clear value for the healthcare system. Geographically company operates in the USA, Netherlands, Singapore, Great Britain, Canada, Switzerland, Curacao, and British Virgin Island.
34GF Score

Get the complete analysis for XSWX:BION

Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF50.60
Price